The FDA has approved the first generic equivalent of Climara Pro, offering a once-weekly transdermal option for managing moderate to severe vasomotor symptoms and preventing postmenopausal ...

A new liquid formulation of cevimeline HCl offers a bioequivalent alternative for adult patients experiencing dry mouth associated with Sjögren disease.

Dostarlimab-gxly demonstrated high rates of sustained clinical complete response that allowed eligible patients to avoid chemotherapy, radiation, and surgery.

The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental New Drug Application (sNDA) for rezafungin (Rezzayo ®) for the prophylaxis of invasive fungal disease.

Strong recommendations made for semiannual surveillance for HCC, testing and vaccination for hepatitis A and B.

The application for the next-generation mitomycin formulation is supported by 3-month complete response data from the phase 3 UTOPIA trial.

The Food and Drug Administration (FDA) has expanded the approval of Ryzumvi ® (phentolamine ophthalmic solution 0.75%) to include the treatment of presbyopia in adults.

Researchers found that mean serum potassium was 4.16 and 4.18mmol/L in the group assigned DASH-patterned groceries and the self-directed group, respectively.

HealthDay News — Undeclared pharmacologically active ingredients (UPAIs) are detected in one-third of over-the-counter (OTC) skin products marketed online, according to a study published online ...

HealthDay News — Structured support may attenuate weight gain after cessation of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), according to a study published online October 7 in Obesity ...

The newly approved autoinjector provides an alternative to the prefilled syringe for daily self-administration.

The FDA has granted over-the-counter approval to Brytly (apraclonidine ophthalmic solution 0.125%) for the symptomatic relief of eye redness due to minor irritation in individuals aged 12 years and ...